NO894573L - Rekombinante interleukin-2 hybridproteiner. - Google Patents

Rekombinante interleukin-2 hybridproteiner.

Info

Publication number: NO894573L
Authority: NO; Norway
Prior art keywords: hybrid proteins; recombinant interleukin; interleukin; recombinant; proteins
Prior art date: 1988-11-17

Application number

NO89894573A

Other languages

English (en)

Norwegian (no)

Other versions

NO894573D0 (no

Inventor

Grace W Ju

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-17

Filing date

1989-11-16

Publication date

1990-05-18

1989-11-16 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1989-11-16 Publication of NO894573D0 publication Critical patent/NO894573D0/no

1990-05-18 Publication of NO894573L publication Critical patent/NO894573L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Hematology (AREA)
Obesity (AREA)
Immunology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Zoology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO89894573A 1988-11-17 1989-11-16 Rekombinante interleukin-2 hybridproteiner. NO894573L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27235688A	1988-11-17	1988-11-17

Publications (2)

Publication Number	Publication Date
NO894573D0 NO894573D0 (no)	1989-11-16
NO894573L true NO894573L (no)	1990-05-18

Family

ID=23039446

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO89894573A NO894573L (no)	1988-11-17	1989-11-16	Rekombinante interleukin-2 hybridproteiner.

Country Status (13)

Country	Link
EP (1)	EP0369316A3 (fr)
JP (1)	JPH02273193A (fr)
AU (1)	AU4474589A (fr)
CA (1)	CA2002854A1 (fr)
DK (1)	DK570589A (fr)
FI (1)	FI895456A7 (fr)
HU (1)	HUT52154A (fr)
IL (1)	IL92316A0 (fr)
MC (1)	MC2072A1 (fr)
NO (1)	NO894573L (fr)
PT (1)	PT92335A (fr)
YU (1)	YU219289A (fr)
ZA (1)	ZA898139B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69019609T2 (de) *	1989-07-07	1995-11-30	Takeda Chemical Industries Ltd	Proteine und deren Herstellung.
FR2653020B1 (fr) *	1989-10-17	1993-03-26	Roussel Uclaf	Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies.
US5594107A (en) *	1990-08-22	1997-01-14	University Of Saskatchewan	Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
US5273889A (en) *	1990-08-22	1993-12-28	University Of Saskatchewan	Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5238823A (en) *	1990-08-22	1993-08-24	Veterinary Infectious Disease Organization	Interleukin-2-leukotoxin gene fusions and uses thereof
EP0547163B1 (fr) *	1990-08-29	2002-02-06	Centre Hospitalier Regional De Nantes	Polyligands de proteine joints a un noyau de proteine stable
US5571507A (en) *	1992-02-25	1996-11-05	Seragen, Inc.	Methods of treating diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ210634A (en) *	1983-12-23	1989-05-29	Hoffmann La Roche	Purification of recombinant human interleukin - 2; pharmaceutical compositions
DE3537461A1 (de) *	1985-10-22	1987-04-23	Hoechst Ag	Derivat des interleukin-2, seine herstellung und verwendung
US4892827A (en) *	1986-09-24	1990-01-09	The United States Of America As Represented By The Department Of Health And Human Services	Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects

1989
- 1989-10-26 ZA ZA898139A patent/ZA898139B/xx unknown
- 1989-11-09 EP EP19890120754 patent/EP0369316A3/fr not_active Withdrawn
- 1989-11-14 DK DK570589A patent/DK570589A/da not_active Application Discontinuation
- 1989-11-14 CA CA002002854A patent/CA2002854A1/fr not_active Abandoned
- 1989-11-15 IL IL92316A patent/IL92316A0/xx unknown
- 1989-11-15 MC MC892075A patent/MC2072A1/fr unknown
- 1989-11-15 HU HU895908A patent/HUT52154A/hu unknown
- 1989-11-16 PT PT92335A patent/PT92335A/pt not_active Application Discontinuation
- 1989-11-16 AU AU44745/89A patent/AU4474589A/en not_active Abandoned
- 1989-11-16 FI FI895456A patent/FI895456A7/fi not_active Application Discontinuation
- 1989-11-16 NO NO89894573A patent/NO894573L/no unknown
- 1989-11-17 YU YU02192/89A patent/YU219289A/xx unknown
- 1989-11-17 JP JP1297759A patent/JPH02273193A/ja active Pending

Also Published As

Publication number	Publication date
EP0369316A2 (fr)	1990-05-23
DK570589A (da)	1990-05-18
NO894573D0 (no)	1989-11-16
AU4474589A (en)	1990-05-24
MC2072A1 (fr)	1990-10-03
HU895908D0 (en)	1990-02-28
FI895456A7 (fi)	1990-05-18
IL92316A0 (en)	1990-07-26
YU219289A (en)	1991-10-31
ZA898139B (en)	1990-08-29
HUT52154A (en)	1990-06-28
DK570589D0 (da)	1989-11-14
PT92335A (pt)	1990-05-31
JPH02273193A (ja)	1990-11-07
FI895456A0 (fi)	1989-11-16
CA2002854A1 (fr)	1990-05-17
EP0369316A3 (fr)	1990-11-22

Publication	Publication Date	Title
FI892714A0 (fi)	1989-06-02	Rekombinant-coccidiosisvaccin.
FI873185L (fi)	1988-01-22	Nya peptider.
FI892136L (fi)	1989-05-03	Rekombinant antikropp.
FI861007L (fi)	1986-09-13	Nya peptider.
FI895860A0 (fi)	1989-12-08	Nya benzoesyra- och fenylaettiksyraderivat.
FI874287A7 (fi)	1988-04-04	Uudet lymfokiinipeptidit.
DE3851238D1 (de)	1994-10-06	Antikoagulierende Peptide.
DE3888921D1 (de)	1994-05-11	Polypeptide.
DE3683186D1 (de)	1992-02-13	Rekombinantes humaninterleukin-1.
NO892294D0 (no)	1989-06-05	Polypeptidforbindelser.
FI894601A0 (fi)	1989-09-28	Nya polyisocyanatsammansaettningar.
FI875324L (fi)	1988-06-06	Hybridproteiner.
NO881384L (no)	1988-10-03	Peptider.
NO885108D0 (no)	1988-11-16	Peptider.
FI892993A0 (fi)	1989-06-19	Nya amidino- och guanidinofoereningar.
FI883257L (fi)	1988-07-07	Nya peptider.
FI900550A7 (fi)	1990-02-02	Hybridiproteiineja
NO894573D0 (no)	1989-11-16	Rekombinante interleukin-2 hybridproteiner.
DK395288D0 (da)	1988-07-15	Proteiner
FI893451L (fi)	1990-01-20	Nya proteiner.
FI895871A0 (fi)	1989-12-08	Nya benzopyranylpyrrolinonderivat.
NO890174D0 (no)	1989-01-13	Rekombinante interleukin-1alfa-polypeptider.
NO892948D0 (no)	1989-07-18	Modifiserte proteiner.
FI864626L (fi)	1987-09-08	Rekombinantricintoxin.
FI893118A0 (fi)	1989-06-27	Nya foereningar.